Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles

Correlation with expression of the Ca2+-ATPase gene

Toshiyuki Takahashi, Paul D. Allen, Seigo Izumo

Research output: Contribution to journalArticle

177 Citations (Scopus)

Abstract

Brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) are novel natriuretic peptides, originally isolated from porcine brain. Similar to atrial natriuretic peptide (ANP), BNP is also synthesized in and secreted from cardiocytes, but CNP is not expressed at significant levels in normal adult myocardium. Previous studies have indicated that the serum level and ventricular expression of the ANP gene were augmented in patients with heart failure. Recently, the serum level of BNP was also reported to increase in human heart failure. To examine whether or not the expression of these natriuretic peptides is regulated in ventricular myocardium in a concordant manner, we performed Northern blot analysis using total cellular RNA isolated from the diseased left ventricles of 30 cardiac transplant recipients with end-stage heart failure, seven ventricles from organ donors (control group), and two ventricles of artificially aborted 17- and 19-week-old fetuses. The levels of mRNAs encoding both BNP and ANP increased significantly (p<0.01) in the left ventricular myocardium from the patients with end-stage heart failure as compared with the control group. The levels of BNP mRNA correlated positively with those of ANP mRNA (r=0.73, p<0.01) and negatively with those of sarcoplasmic reticulum Ca2+-ATPaSe mRNA (r=-0.66, p<0.01) in the left ventricular myocardium from the patients with heart failure. There was also a negative correlation between the levels of ANP and the sarcoplasmic reticulum Ca2+-ATPaSe mRNAs (r=-0.65, p<0.01). In fetal myocardium, ventricular expression of ANP mRNA was higher and that of BNP mRNA was unchanged as compared with adult control myocardium. In contrast, CNP mRNA was not detectable by Northern blot analysis in either the normal, fetal, or diseased ventricular myocardium. These data suggest that ventricular expression of BNP and ANP mRNAs is concordantly regulated in patients with end-stage heart failure and that this coexpression of these two natriuretic peptides may play an important role in a compensatory process in human heart failure. In contrast, expression of BNP and ANP is discordantly regulated in the fetal ventricles, and CNP is probably never expressed at the significant level detectable by Northern blot analysis in the ventricles either during development or in disease states.

Original languageEnglish (US)
Pages (from-to)9-17
Number of pages9
JournalCirculation Research
Volume71
Issue number1
StatePublished - Jul 1992
Externally publishedYes

Fingerprint

C-Type Natriuretic Peptide
Calcium-Transporting ATPases
Brain Natriuretic Peptide
Atrial Natriuretic Factor
Myocardium
Messenger RNA
Heart Failure
Genes
Natriuretic Peptides
Northern Blotting
Sarcoplasmic Reticulum
Fetal Diseases
Control Groups
Serum
Heart Ventricles
Fetus
Swine
Tissue Donors
RNA

Keywords

  • Atrial natriuretic peptide
  • Brain natriuretic peptide
  • C-type natriuretic peptide
  • Fetal heart
  • Heart failure
  • Human Ca-ATPase
  • Left ventricular myocardium

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles : Correlation with expression of the Ca2+-ATPase gene. / Takahashi, Toshiyuki; Allen, Paul D.; Izumo, Seigo.

In: Circulation Research, Vol. 71, No. 1, 07.1992, p. 9-17.

Research output: Contribution to journalArticle

@article{a4b9f8792c0147d0b3c08962c4507621,
title = "Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles: Correlation with expression of the Ca2+-ATPase gene",
abstract = "Brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) are novel natriuretic peptides, originally isolated from porcine brain. Similar to atrial natriuretic peptide (ANP), BNP is also synthesized in and secreted from cardiocytes, but CNP is not expressed at significant levels in normal adult myocardium. Previous studies have indicated that the serum level and ventricular expression of the ANP gene were augmented in patients with heart failure. Recently, the serum level of BNP was also reported to increase in human heart failure. To examine whether or not the expression of these natriuretic peptides is regulated in ventricular myocardium in a concordant manner, we performed Northern blot analysis using total cellular RNA isolated from the diseased left ventricles of 30 cardiac transplant recipients with end-stage heart failure, seven ventricles from organ donors (control group), and two ventricles of artificially aborted 17- and 19-week-old fetuses. The levels of mRNAs encoding both BNP and ANP increased significantly (p<0.01) in the left ventricular myocardium from the patients with end-stage heart failure as compared with the control group. The levels of BNP mRNA correlated positively with those of ANP mRNA (r=0.73, p<0.01) and negatively with those of sarcoplasmic reticulum Ca2+-ATPaSe mRNA (r=-0.66, p<0.01) in the left ventricular myocardium from the patients with heart failure. There was also a negative correlation between the levels of ANP and the sarcoplasmic reticulum Ca2+-ATPaSe mRNAs (r=-0.65, p<0.01). In fetal myocardium, ventricular expression of ANP mRNA was higher and that of BNP mRNA was unchanged as compared with adult control myocardium. In contrast, CNP mRNA was not detectable by Northern blot analysis in either the normal, fetal, or diseased ventricular myocardium. These data suggest that ventricular expression of BNP and ANP mRNAs is concordantly regulated in patients with end-stage heart failure and that this coexpression of these two natriuretic peptides may play an important role in a compensatory process in human heart failure. In contrast, expression of BNP and ANP is discordantly regulated in the fetal ventricles, and CNP is probably never expressed at the significant level detectable by Northern blot analysis in the ventricles either during development or in disease states.",
keywords = "Atrial natriuretic peptide, Brain natriuretic peptide, C-type natriuretic peptide, Fetal heart, Heart failure, Human Ca-ATPase, Left ventricular myocardium",
author = "Toshiyuki Takahashi and Allen, {Paul D.} and Seigo Izumo",
year = "1992",
month = "7",
language = "English (US)",
volume = "71",
pages = "9--17",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles

T2 - Correlation with expression of the Ca2+-ATPase gene

AU - Takahashi, Toshiyuki

AU - Allen, Paul D.

AU - Izumo, Seigo

PY - 1992/7

Y1 - 1992/7

N2 - Brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) are novel natriuretic peptides, originally isolated from porcine brain. Similar to atrial natriuretic peptide (ANP), BNP is also synthesized in and secreted from cardiocytes, but CNP is not expressed at significant levels in normal adult myocardium. Previous studies have indicated that the serum level and ventricular expression of the ANP gene were augmented in patients with heart failure. Recently, the serum level of BNP was also reported to increase in human heart failure. To examine whether or not the expression of these natriuretic peptides is regulated in ventricular myocardium in a concordant manner, we performed Northern blot analysis using total cellular RNA isolated from the diseased left ventricles of 30 cardiac transplant recipients with end-stage heart failure, seven ventricles from organ donors (control group), and two ventricles of artificially aborted 17- and 19-week-old fetuses. The levels of mRNAs encoding both BNP and ANP increased significantly (p<0.01) in the left ventricular myocardium from the patients with end-stage heart failure as compared with the control group. The levels of BNP mRNA correlated positively with those of ANP mRNA (r=0.73, p<0.01) and negatively with those of sarcoplasmic reticulum Ca2+-ATPaSe mRNA (r=-0.66, p<0.01) in the left ventricular myocardium from the patients with heart failure. There was also a negative correlation between the levels of ANP and the sarcoplasmic reticulum Ca2+-ATPaSe mRNAs (r=-0.65, p<0.01). In fetal myocardium, ventricular expression of ANP mRNA was higher and that of BNP mRNA was unchanged as compared with adult control myocardium. In contrast, CNP mRNA was not detectable by Northern blot analysis in either the normal, fetal, or diseased ventricular myocardium. These data suggest that ventricular expression of BNP and ANP mRNAs is concordantly regulated in patients with end-stage heart failure and that this coexpression of these two natriuretic peptides may play an important role in a compensatory process in human heart failure. In contrast, expression of BNP and ANP is discordantly regulated in the fetal ventricles, and CNP is probably never expressed at the significant level detectable by Northern blot analysis in the ventricles either during development or in disease states.

AB - Brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP) are novel natriuretic peptides, originally isolated from porcine brain. Similar to atrial natriuretic peptide (ANP), BNP is also synthesized in and secreted from cardiocytes, but CNP is not expressed at significant levels in normal adult myocardium. Previous studies have indicated that the serum level and ventricular expression of the ANP gene were augmented in patients with heart failure. Recently, the serum level of BNP was also reported to increase in human heart failure. To examine whether or not the expression of these natriuretic peptides is regulated in ventricular myocardium in a concordant manner, we performed Northern blot analysis using total cellular RNA isolated from the diseased left ventricles of 30 cardiac transplant recipients with end-stage heart failure, seven ventricles from organ donors (control group), and two ventricles of artificially aborted 17- and 19-week-old fetuses. The levels of mRNAs encoding both BNP and ANP increased significantly (p<0.01) in the left ventricular myocardium from the patients with end-stage heart failure as compared with the control group. The levels of BNP mRNA correlated positively with those of ANP mRNA (r=0.73, p<0.01) and negatively with those of sarcoplasmic reticulum Ca2+-ATPaSe mRNA (r=-0.66, p<0.01) in the left ventricular myocardium from the patients with heart failure. There was also a negative correlation between the levels of ANP and the sarcoplasmic reticulum Ca2+-ATPaSe mRNAs (r=-0.65, p<0.01). In fetal myocardium, ventricular expression of ANP mRNA was higher and that of BNP mRNA was unchanged as compared with adult control myocardium. In contrast, CNP mRNA was not detectable by Northern blot analysis in either the normal, fetal, or diseased ventricular myocardium. These data suggest that ventricular expression of BNP and ANP mRNAs is concordantly regulated in patients with end-stage heart failure and that this coexpression of these two natriuretic peptides may play an important role in a compensatory process in human heart failure. In contrast, expression of BNP and ANP is discordantly regulated in the fetal ventricles, and CNP is probably never expressed at the significant level detectable by Northern blot analysis in the ventricles either during development or in disease states.

KW - Atrial natriuretic peptide

KW - Brain natriuretic peptide

KW - C-type natriuretic peptide

KW - Fetal heart

KW - Heart failure

KW - Human Ca-ATPase

KW - Left ventricular myocardium

UR - http://www.scopus.com/inward/record.url?scp=0026762994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026762994&partnerID=8YFLogxK

M3 - Article

VL - 71

SP - 9

EP - 17

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -